Cattle & Porcine/Swine Reproductive Diseases Market: Growth, Size, Share, and Trends

Report Code MD 9200
Published in Oct, 2024, By MarketsandMarkets™
Download PDF

Choose License Type

Buy Report Now Inquire Before Buying

Cattle & Porcine/Swine Reproductive Diseases Market by Product (Diagnostics (ELISA, PCR, Rapid Antigen Testing), Pharmaceuticals (Vaccines), Supplements, Animal Type, Disease (BVD, PRRS, Leptospirosis, Brucellosis), End User - Global Forecast to 2029

Overview

The global Cattle & Porcine/Swine Reproductive Diseases market, valued at US$726.9 million in 2023, is forecasted to grow at a robust CAGR of 5.2%, reaching US$758.2 million in 2024 and an impressive US$975.8 million by 2029. Increasing investments, funding, and grants from various governments and organizations to improve animal health, along with a growing number of veterinarians in developing nations, are enhancing the treatment of diseases. This is a key driver for the cattle & porcine/swine reproductive diseases market. The increasing consumption of animal protein due to the growth of the human population also contributes to the market's expansion. Technological advances, such as new vaccines and reproductive technologies, further support this growth. However, a lack of awareness and education among small-scale farmers could hinder market development. Targeted training and awareness programs addressing these educational gaps are crucial to ensure the widespread adoption of advanced disease management practices, which would support continued market growth and improve general livestock health.

Attractive Opportunities in the Cattle & Porcine/Swine Reproductive Diseases Market

Asia Pacific

Growth in the APAC market can be attributed to the increasing production of animal-derived food, the growing number of government and animal association initiatives, and the growth of the farm animal population.

Market expansion is primarily fueled by factors such as increasing awareness, technological advancements, investments in research and development, and educational programs to promote animal welfare.

Collaborations, partnerships, and agreements are set to offer attractive growth opportunities for market participants in the near future.

The APAC cattle and porcine reproductive diseases market is expected to grow at a CAGR of 6.3% during the forecast period.

Stringent regulatory policies in the livestock farming industry and a lack of awareness among small-scale farmers are obstacles to market growth

Global Cattle & Porcine/Swine Reproductive Diseases Market Dynamics

DRIVER: Increasing Per Capita Income of Farmers in Developing Countries

The growing per capita income of farmers in developing nations is a great opportunity for the cattle & porcine/swine reproductive diseases market. In developing countries, such as India and China, increasing incomes and investments result in improving farming standards and animal health management, including reproductive health. In India, the rural per capita income increased by 17.4% between 2015 and 2020, reflecting a developing ability and propensity among farmers to improve farming standards. Likewise, increasing incomes in rural China reflect improved buying power and a shift towards high-quality farm inputs. The same trend is being incentivized by governments of developing countries through subsidies and other motives to improve agriculture production. For instance, the policies in Brazil and Indonesia aim to improve rural incomes as well as agricultural production and, as such, create a favorable environment that can foster growth in the market for cattle and porcine reproductive diseases. As the incomes of farmers continue to improve, reproductive health products like vaccines, antibiotics, and diagnostic tools will register an upward trend while future development and innovation in this field are warranted.

RESTRAINT: Lack of Awareness and Knowledge Among Small-Scale Farmers

The lack of awareness and knowledge among small-scale farmers has been a hindering factor in the cattle & porcine/swine reproductive diseases market. Farmers, because of this fact, have less access to veterinary services and modern agricultural education and are thus not aware of the importance of disease prevention and control measures. For instance, early signs of reproductive diseases such as brucellosis may not be noticeable by most small-scale farmers, often leading to late treatments and high rates of infection in herds. This will indeed have adverse implications on the health of the animals and their productivity, thereby leading to financial losses. Besides, small-scale farmers may also remain unaware of the latest vaccines or treatments available for preventing such diseases. According to a study by FAO, lack of access to information and veterinary services has been acting as one of the major hurdles toward disease control in most rural areas. In the absence of proper knowledge and resources, farmers are not able to protect their livestock efficiently, which ultimately restrains the growth of the market.

 

OPPORTUNITY: Advancements in Veterinary Healthcare

Advancements in the healthcare industry are offering vast opportunities for the cattle & porcine/swine reproductive diseases market. New diagnostic technologies help veterinarians identify reproductive diseases more precisely and much faster. For example, the development of multiplex PCR assays forms the basis for the detection of several pathogens in one test and thus improves efficiency. Besides, innovations in vaccine development address specific reproductive diseases. This is through the recent development of vaccines for diseases such as bovine viral diarrhea (BVD) that has tightened disease control and resulted in healthier livestock and loss reduction in farmers. These advances in diagnostics and vaccines are important in managing and preventing reproductive diseases in cattle and pigs.

CHALLENGES: Regulatory Control in Livestock Industry

The cattle and porcine reproductive disease market is under very stringent regulatory oversight, with the USDA, US FDA, Canadian Food Inspection Agency, European Medicines Agency, MAFF, and APVMA having rigid guidelines for approvals related to veterinary products. Such products include anti-microbials, antibiotics, vaccines, and hygiene products, among others, which are very significant in addressing diseases among livestock. The VICH also provides harmonization between the US, Europe, and Japan to minimize complications while registering the products. On the other hand, the development and approval of new veterinary pharmaceuticals for cattle and pigs are usually long and costly. Development time ranges from 5 to 11 years whereas the estimated cost stands at USD 75–100 million. This means that the tight regulatory requirements have accordingly made it a big barrier to innovation, particularly in the development of new treatments for pain management in livestock. This discourages some market players from investing in new product development.

Global Cattle & Porcine/Swine Reproductive Diseases Market Ecosystem Analysis

This report segments the cattle & porcine/swine reproductive diseases market by product, disease type, animal type, end user, and region.

 

By product, the pharmaceuticals segment is expected to witness the second-highest CAGR in the cattle & porcine/swine reproductive diseases market.

The diagnostics segment is expected to grow rapidly due to advancements in diagnostic technologies. These technologies are improving the speed and accuracy of onsite tests for disease recognition. Newer tools are helping veterinarians quickly identify issues, leading to better treatment outcomes and increasing the demand for diagnostic services. Additionally, there is a rising awareness of animal health, leading to early identification of health issues. As a result, more farmers and vets are investing in advanced diagnostics to prevent outbreaks and ensure herd productivity. All of these factors contribute to a faster growth rate in the diagnostics segment compared to other areas in the market.

By disease type, the bovine viral diarrhea (BVD) segment accounted the largest share of the cattle & porcine/swine reproductive diseases market.

By disease type, the bovine viral diarrhea (BVD) segment dominates the cattle & porcine/swine reproductive diseases market because it affects a large population of cattle across the globe, causing them enormous economic losses through diminished milk yield and inferior quality of meat. There are many symptoms and complications associated with the disease, which necessitates proper management for the farmer and veterinarian alike. Likewise, in order to control and eradicate BVD, strong regulatory attention and efforts from the industry have driven an increased demand for related products and services. As the strategies to address BVD become more focused and effective, the market for solutions addressing this disease continues to expand.

The cattle segment accounted for the largest market share of the cattle & porcine/swine reproductive diseases market, by animal type.

The cattle segment captured the largest share in this market in 2023, mainly due to several reasons associated with rearing cattle. Other contributing factors include a growing interest in cattle health. The cattle farming industry is huge, especially in parts where the production of milk and beef forms the backbone of their national economies. Consequently, there is a significant focus on cattle health. Bovine reproductive disorders, such as BVD and brucellosis, have a substantial impact on herd productivity and profitability, highlighting the need for effective treatment and prevention. Compared to swine, cattle are more susceptible to reproductive diseases, requiring a wider range of veterinary services and products. Additionally, the increasing global consumption of dairy and meat creates a higher demand for healthy cattle populations, leading to market expansion.

By end user, cattle and porcine farms witnessed the highest CAGR in the cattle & porcine/swine reproductive diseases market.

The cattle and porcine farms segment is the fastest-growing segment in the cattle & porcine/swine reproductive diseases market by end user. This is largely because increasing the scale of farming operations means larger herds, which heightens the risk of disease outbreaks and drives demand for effective disease management solutions. Furthermore, advanced technology and efficient management on farms contribute to improved disease monitoring and control. As a result, these farms are more inclined to invest in the latest diagnostics and treatments. Additionally, due to their focus on maximizing productivity and profitability, modern farms are more committed to comprehensive disease prevention programs in order to minimize losses and maintain healthy livestock. The increasing emphasis on disease management and farm efficiency means that these companies are making a significant contribution to the rapid growth in this market segment.

Europe Holds the Largest Share in the Cattle & Porcine/Swine Reproductive Diseases Market, by Region

Europe accounted for the largest share of the cattle & porcine/swine reproductive diseases market. This is largely because the established agricultural infrastructure in the region is supportive of widespread livestock farming. In most European countries, this demand is mostly driven by strict animal health regulations along with monitoring programs. In this way, such regulations ensure that animal health and welfare maintain a high standard, thus allowing for more investments in disease control measures. Moreover, government initiatives in European countries include the funding of programs in the field of disease prevention, alongside financial innovation support for technologies that give additional support to the market.

HIGHEST CAGR MARKET IN 2024-2030
GERMANY FASTEST GROWING MARKET IN THE REGION

Recent Developments of Cattle & Porcine/Swine Reproductive Diseases Market

  • In July 2024, Ring Biotechnology Co. Ltd. (China) launched a multispecies Brucella antibody ELISA kit. This kit offers unparalleled accuracy and sensitivity in detecting antibodies against Brucella species, providing vets and researchers with a powerful tool to combat this devastating group of pathogens.
  • In March 2024, Zoetis Inc. (US) announced the purchase of a 21-acre manufacturing site in Melbourne to significantly expand its current operations and increase its future capabilities to develop and manufacture vaccines.

Key Market Players

Want to explore hidden markets that can drive new revenue in Cattle & Porcine/Swine Reproductive Diseases Market?

Scope of the Report

Report Metric Details
Market size available for years 2021-2029
Base Year Considered 2023
Forecast period 2024-2029
Forecast units Value(USD Million/Billion)
Segments covered Cattle & porcine/swine reproductive diseases market: Product, Disease, Animal and End User
Geographies covered North America, Europe, Asia Pacific, Latin America, Middle East & Africa

 

Key Questions Addressed by the Report

Which are the top industry players in the global cattle & porcine/swine reproductive diseases market?
The top market players in the global cattle & porcine/swine reproductive diseases market are Zoetis Inc. (US), Merck & Co., Inc. (US), Boehringer Ingelheim International GmbH (Germany), Virbac (France), Elanco Animal Health Incorporated (US), Vetoquinol S.A. (France), Ceva Santé Animale (France), IDEXX Laboratories (US), Thermo Fisher Scientific Inc. (US), BioChek Smart Veterinary Diagnostics (Netherlands), Ring Biotechnology Co Ltd. (China), Sequent Scientific Limited (India), HIPRA (Spain), QIAGEN N.V. (Germany), and Innovative Diagnostics (France).
Which are the segments that have been included in this report?
This report has the following main segments:
  • By Product
  • By Disease Type
  • By Animal Type
  • By End User
  • By Region
Which geographical region dominates the cattle & porcine/swine reproductive diseases market?
The global cattle & porcine/swine reproductive diseases market is categorized into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Europe emerged as the dominant region in 2023, owing to several factors, including technological advancements in the devices used in this market, increasing R&D investments, and surging governmental support.
Which product segment dominates the cattle & porcine/swine reproductive diseases market?
The pharmaceuticals segment accounted for the largest market share in 2023, followed by the diagnostics segment.
Which end-user segment dominates the cattle & porcine/swine reproductive diseases market?
The cattle & porcine farms segment accounted for the largest share of the market in 2023 due to the rising demand for animal-derived food products.

 

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Cattle & Porcine/Swine Reproductive Diseases Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
INTRODUCTION
29
RESEARCH METHODOLOGY
34
EXECUTIVE SUMMARY
49
PREMIUM INSIGHTS
55
MARKET OVERVIEW
58
  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    DRIVERS
    - Growing demand for animal−derived food products
    - Increasing prevalence of reproductive health issues
    - Rising number of veterinary practitioners in developed markets
    - Increasing per capita income of farmers in emerging markets
    RESTRAINTS
    - Limited awareness & education among small-scale farmers
    OPPORTUNITIES
    - Advancements in veterinary healthcare
    - High growth potential of emerging economies
    CHALLENGES
    - Stringent regulatory guidelines for livestock industry
  • 5.3 INDUSTRY TRENDS
    INCREASING ADOPTION OF VACCINATION PROGRAMS
    EMPHASIS ON SUSTAINABLE PRACTICES
  • 5.4 TECHNOLOGY ANALYSIS
    KEY TECHNOLOGIES
    - Vaccination technologies
    - Diagnostic tools
    COMPLEMENTARY TECHNOLOGIES
    - Genomic selection & breeding
    - Precision livestock farming
    ADJACENT TECHNOLOGIES
    - Nutritional supplements & additives
    - Integration of livestock management software
  • 5.5 PORTER’S FIVE FORCES ANALYSIS
    THREAT OF NEW ENTRANTS
    BARGAINING POWER OF SUPPLIERS
    BARGAINING POWER OF BUYERS
    THREAT OF SUBSTITUTES
    COMPETITIVE RIVALRY
  • 5.6 KEY STAKEHOLDERS AND BUYING CRITERIA
    KEY STAKEHOLDERS IN BUYING PROCESS
    BUYING CRITERIA
  • 5.7 REGULATORY LANDSCAPE
    REGULATORY ANALYSIS
    REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.8 PATENT ANALYSIS
    PATENT PUBLICATION TRENDS FOR CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET
    INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
  • 5.9 TRADE ANALYSIS
    TRADE ANALYSIS FOR CATTLE & PORCINE REPRODUCTIVE PRODUCTS
  • 5.10 PRICING ANALYSIS
    AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY TYPE
    AVERAGE SELLING PRICE TREND OF CATTLE & PORCINE REPRODUCTIVE HEALTH PRODUCTS, BY REGION
  • 5.11 REIMBURSEMENT ANALYSIS
  • 5.12 KEY CONFERENCES AND EVENTS
  • 5.13 UNMET NEEDS/END-USER EXPECTATIONS IN CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET
  • 5.14 IMPACT OF GEN AI ON CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET
  • 5.15 ECOSYSTEM ANALYSIS
  • 5.16 CASE STUDY ANALYSIS
    INNOVATION IN BOVINE REPRODUCTIVE DISEASE VACCINATION
    TECH-DRIVEN SOLUTIONS FOR LIVESTOCK REPRODUCTIVE HEALTH
    INTEGRATED HEALTH SOLUTIONS FOR CATTLE REPRODUCTIVE HEALTH
  • 5.17 SUPPLY CHAIN ANALYSIS
  • 5.18 VALUE CHAIN ANALYSIS
  • 5.19 ADJACENT MARKETS FOR CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET
  • 5.20 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESSES
  • 5.21 INVESTMENT & FUNDING SCENARIO
CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY PRODUCT
99
  • 6.1 INTRODUCTION
  • 6.2 DIAGNOSTICS
    ELISA TEST KITS
    - Advancements in biotechnology to drive market
    PCR TEST KITS
    - Increasing adoption of on-farm PCR testing solutions to fuel uptake
    RAPID ANTIGEN TEST KITS
    - Growing demand for reliable solutions with quick turnaround time to drive market
    OTHER DIAGNOSTIC PRODUCTS
  • 6.3 PHARMACEUTICALS
    VACCINES
    - Enhancements in vaccine technology & formulation to drive market
    ANTIBIOTICS
    - Convenient purchase options and long-term benefits to boost demand
    HORMONAL THERAPY
    - Ability to mimic natural hormones to boost demand
    OTHER PHARMACEUTICAL PRODUCTS
  • 6.4 SUPPLEMENTS
    VITAMINS & MINERALS
    - Rising focus on nutrition and reproductive health to support market growth
    OTHER SUPPLEMENTS
CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY DISEASE TYPE
127
  • 7.1 INTRODUCTION
  • 7.2 LEPTOSPIROSIS
    RISING CASES DUE TO CLIMATE CHANGE TO DRIVE MARKET
  • 7.3 BRUCELLOSIS
    IMPACT ON LIVESTOCK PRODUCTIVITY DUE TO CONTAGIOUS NATURE TO SUPPORT MARKET GROWTH
  • 7.4 PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME (PRRS)
    INCREASING PORK CONSUMPTION TO PROPEL MARKET
  • 7.5 BOVINE VIRAL DIARRHEA (BVD)
    HIGH MORBIDITY RATE TO DRIVE MARKET
  • 7.6 VIBRIOSIS
    GROWING DEMAND FOR HIGH-YIELDING LIVESTOCK TO SUPPORT MARKET GROWTH
  • 7.7 OTHER CATTLE & PORCINE DISEASES
CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY ANIMAL TYPE
141
  • 8.1 INTRODUCTION
  • 8.2 CATTLE
    DAIRY CATTLE
    - Increasing demand for milk & dairy products to boost demand
    BEEF CATTLE
    - Increasing demand for beef to drive market
  • 8.3 PORCINE
CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY END USER
151
  • 9.1 INTRODUCTION
  • 9.2 CATTLE & PORCINE FARMS
    GROWING DEMAND FOR MEAT & DAIRY PRODUCTS TO DRIVE MARKET
  • 9.3 VETERINARY HOSPITALS & CLINICS
    INCREASING VETERINARY HEALTHCARE INVESTMENTS IN EMERGING MARKETS TO BOOST DEMAND
  • 9.4 VETERINARY REFERENCE LABORATORIES
    INCREASING TECHNOLOGICAL ADVANCEMENTS IN VETERINARY DIAGNOSTICS TO SUPPORT MARKET GROWTH
    CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY REGION
CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY REGION
152
  • 10.1 INTRODUCTION
  • 10.2 NORTH AMERICA
    MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    US
    - Large-scale livestock operations and advanced veterinary practices to drive market
    CANADA
    - Rising concerns about food safety & quality to fuel market
  • 10.3 EUROPE
    MACROECONOMIC OUTLOOK FOR EUROPE
    GERMANY
    - Adoption of advanced technologies for milk & dairy products to drive market
    UK
    - Favorable government support for animal healthcare to boost demand
    FRANCE
    - Growth in veterinary & healthcare industries to drive market
    ITALY
    - Growing focus on swine & dairy farming to fuel uptake
    SWITZERLAND
    - Technologically advanced agriculture sector to fuel market
    SPAIN
    - High exports of meat & milk to contribute to market growth
    REST OF EUROPE
  • 10.4 ASIA PACIFIC
    MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    JAPAN
    - Rising focus on dairy industry to drive market
    CHINA
    - Rising prevalence of infectious diseases in livestock to propel market
    INDIA
    - Expanding cattle population to boost demand
    AUSTRALIA
    - Emphasis on sustainable & systematic farming practices to support market growth
    SOUTH KOREA
    - Rise in pork & beef consumption to drive market
    REST OF ASIA PACIFIC
  • 10.5 LATIN AMERICA
    MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    BRAZIL
    - Growing demand for veterinary services to fuel uptake
    MEXICO
    - Improvements in animal welfare to support market growth
    REST OF LATIN AMERICA
  • 10.6 MIDDLE EAST & AFRICA
    MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
    GCC COUNTRIES
    - Growing demand for dairy to fuel market
    REST OF MIDDLE EAST & AFRICA
COMPETITIVE LANDSCAPE
248
  • 11.1 OVERVIEW
  • 11.2 KEY PLAYER STRATEGY/RIGHT TO WIN
  • 11.3 REVENUE ANALYSIS
  • 11.4 MARKET SHARE ANALYSIS
    RANKING OF KEY MARKET PLAYERS
  • 11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    STARS
    EMERGING LEADERS
    PERVASIVE PLAYERS
    PARTICIPANTS
    COMPANY FOOTPRINT: KEY PLAYERS, 2023
    - Company footprint
    - Product footprint
    - Disease type footprint
    - Animal type footprint
    - End-user footprint
    - Region footprint
  • 11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    PROGRESSIVE COMPANIES
    DYNAMIC COMPANIES
    STARTING BLOCKS
    RESPONSIVE COMPANIES
    COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
  • 11.7 COMPANY VALUATION & FINANCIAL METRICS
    COMPANY VALUATION
    FINANCIAL METRICS
  • 11.8 BRAND/PRODUCT COMPARISON
  • 11.9 R&D EXPENDITURE OF KEY PLAYERS
  • 11.10 COMPETITIVE SCENARIO
    PRODUCT APPROVALS/LAUNCHES
    DEALS
    EXPANSIONS
    OTHER DEVELOPMENTS
COMPANY PROFILES
270
  • 12.1 KEY PLAYERS
    ZOETIS INC.
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    MERCK & CO., INC.
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    VIRBAC
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    ELANCO ANIMAL HEALTH INCORPORATED
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    VETOQUINOL S.A.
    - Business overview
    - Products offered
    CEVA SANTÉ ANIMALE
    - Business overview
    - Products offered
    - Recent developments
    IDEXX LABORATORIES, INC.
    - Business overview
    - Products offered
    - Recent developments
    THERMO FISHER SCIENTIFIC INC.
    - Business overview
    - Products offered
    BIOCHEK SMART VETERINARY DIAGNOSTICS
    - Business overview
    - Products offered
    - Recent developments
    RING BIOTECHNOLOGY CO LTD.
    - Business overview
    - Products offered
    - Recent developments
    SEQUENT SCIENTIFIC LIMITED
    - Business overview
    - Products offered
    HIPRA
    - Business overview
    - Products offered
    QIAGEN N.V.
    - Business overview
    - Products offered
    INNOVATIVE DIAGNOSTICS
    - Business overview
    - Products offered
    - Recent developments
  • 12.2 OTHER PLAYERS
    COLORADO SERUM COMPANY
    INDIAN IMMUNOLOGICALS LTD.
    REFIT ANIMAL CARE
    CALIER
    MEGACOR DIAGNOSTIK GMBH
    VETANCO
    BIOGENESIS BAGO
    ADVACARE PHARMA
    BIO-X DIAGNOSTICS S.A.
    PAX HEALTHCARE
APPENDIX
323
  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
  • 13.3 CUSTOMIZATION OPTIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS
List of Tables
324
  • 14.1 TABLE 1 STANDARD CURRENCY CONVERSION RATES (UNIT OF USD)
  • 14.2 TABLE 2 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET: STUDY ASSUMPTION ANALYSIS
  • 14.3 TABLE 3 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET: RISK ASSESSMENT ANALYSIS
  • 14.4 TABLE 4 PAST & PROJECTED TRENDS IN CONSUMPTION OF MEAT & MILK IN DEVELOPED AND EMERGING MARKETS (2002−2030)
  • 14.5 TABLE 5 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET: PORTER’S FIVE FORCES ANALYSIS
  • 14.6 TABLE 6 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END USER
  • 14.7 TABLE 7 KEY BUYING CRITERIA FOR TOP THREE END USERS
  • 14.8 TABLE 8 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 14.9 TABLE 9 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 14.10 TABLE 10 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 14.11 TABLE 11 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 14.12 TABLE 12 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET: LIST OF MAJOR PATENTS
  • 14.13 TABLE 13 IMPORT AND EXPORT DATA FOR PRODUCTS RELATED TO CATTLE, PORCINE, REPRODUCTIVE, BY COUNTRY
  • 14.14 TABLE 14 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY TYPE
  • 14.15 TABLE 15 AVERAGE SELLING PRICE OF CATTLE & PORCINE REPRODUCTIVE HEALTH PRODUCTS, BY REGION
  • 14.16 TABLE 16 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET: DETAILED LIST OF CONFERENCES AND EVENTS (2024−2025)
  • 14.17 TABLE 17 UNMET NEEDS/END-USER EXPECTATIONS IN CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET
  • 14.18 TABLE 18 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET: IMPACT OF GEN AI
  • 14.19 TABLE 19 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET: ROLE IN ECOSYSTEM
  • 14.20 TABLE 20 CASE STUDY ONE: INNOVATION IN BOVINE REPRODUCTIVE DISEASE VACCINATION BY ZOETIS, INC.
  • 14.21 TABLE 21 CASE STUDY TWO: TECH-DRIVEN SOLUTIONS FOR LIVESTOCK REPRODUCTIVE HEALTH BY CEVA SANTÉ ANIMALE (FRANCE)
  • 14.22 TABLE 22 CASE STUDY THREE: INTEGRATED HEALTH SOLUTIONS FOR CATTLE REPRODUCTIVE HEALTH BY ELANCO ANIMAL HEALTH
  • 14.23 TABLE 23 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • 14.24 TABLE 24 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR DIAGNOSTICS, BY TYPE, 2022–2029 (USD MILLION)
  • 14.25 TABLE 25 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • 14.26 TABLE 26 ELISA TEST KITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • 14.27 TABLE 27 PCR TEST KITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • 14.28 TABLE 28 RAPID ANTIGEN TEST KITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • 14.29 TABLE 29 OTHER DIAGNOSTIC PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • 14.30 TABLE 30 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR PHARMACEUTICALS, BY TYPE, 2022–2029 (USD MILLION)
  • 14.31 TABLE 31 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR PHARMACEUTICALS, BY COUNTRY, 2022–2029 (USD MILLION)
  • 14.32 TABLE 32 VACCINES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • 14.33 TABLE 33 ANTIBIOTICS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • 14.34 TABLE 34 HORMONAL THERAPY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • 14.35 TABLE 35 OTHER PHARMACEUTICAL PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • 14.36 TABLE 36 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR SUPPLEMENTS, BY TYPE, 2022–2029 (USD MILLION)
  • 14.37 TABLE 37 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR SUPPLEMENTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • 14.38 TABLE 38 VITAMINS & MINERALS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • 14.39 TABLE 39 OTHER SUPPLEMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • 14.40 TABLE 40 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY DISEASE TYPE, 2022–2029 (USD MILLION)
  • 14.41 TABLE 41 LEPTOSPIROSIS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • 14.42 TABLE 42 BRUCELLOSIS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • 14.43 TABLE 43 PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • 14.44 TABLE 44 BOVINE VIRAL DIARRHEA (BVD) MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • 14.45 TABLE 45 VIBRIOSIS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • 14.46 TABLE 46 OTHER CATTLE & PORCINE DISEASES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • 14.47 TABLE 47 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY ANIMAL TYPE, 2022–2029 (USD MILLION)
  • 14.48 TABLE 48 CATTLE REPRODUCTIVE DISEASES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • 14.49 TABLE 49 CATTLE REPRODUCTIVE DISEASES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • 14.50 TABLE 50 DAIRY CATTLE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • 14.51 TABLE 51 BEEF CATTLE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • 14.52 TABLE 52 PORCINE REPRODUCTIVE DISEASES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • 14.53 TABLE 53 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • 14.54 TABLE 54 CATTLE & PORCINE FARMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • 14.55 TABLE 55 VETERINARY HOSPITALS & CLINICS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • 14.56 TABLE 56 VETERINARY REFERENCE LABORATORIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • 14.57 TABLE 57 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • 14.58 TABLE 58 NORTH AMERICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • 14.59 TABLE 59 NORTH AMERICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • 14.60 TABLE 60 NORTH AMERICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR DIAGNOSTICS, BY TYPE, 2022–2029 (USD MILLION)
  • 14.61 TABLE 61 NORTH AMERICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR PHARMACEUTICALS, BY TYPE, 2022–2029 (USD MILLION)
  • 14.62 TABLE 62 NORTH AMERICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR SUPPLEMENTS, BY TYPE, 2022–2029 (USD MILLION)
  • 14.63 TABLE 63 NORTH AMERICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY DISEASE TYPE, 2022–2029 (USD MILLION)
  • 14.64 TABLE 64 NORTH AMERICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY ANIMAL TYPE, 2022–2029 (USD MILLION)
  • 14.65 TABLE 65 NORTH AMERICA: CATTLE REPRODUCTIVE DISEASES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • 14.66 TABLE 66 NORTH AMERICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • 14.67 TABLE 67 US: KEY MACROINDICATORS
  • 14.68 TABLE 68 US: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • 14.69 TABLE 69 US: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR DIAGNOSTICS, BY TYPE, 2022–2029 (USD MILLION)
  • 14.70 TABLE 70 US: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR PHARMACEUTICALS, BY TYPE, 2022–2029 (USD MILLION)
  • 14.71 TABLE 71 US: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR SUPPLEMENTS, BY TYPE, 2022–2029 (USD MILLION)
  • 14.72 TABLE 72 US: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY DISEASE TYPE, 2022–2029 (USD MILLION)
  • 14.73 TABLE 73 US: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY ANIMAL TYPE, 2022–2029 (USD MILLION)
  • 14.74 TABLE 74 US: CATTLE REPRODUCTIVE DISEASES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • 14.75 TABLE 75 US: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • 14.76 TABLE 76 CANADA: KEY MACROINDICATORS
  • 14.77 TABLE 77 CANADA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • 14.78 TABLE 78 CANADA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR DIAGNOSTICS, BY TYPE, 2022–2029 (USD MILLION)
  • 14.79 TABLE 79 CANADA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR PHARMACEUTICALS, BY TYPE, 2022–2029 (USD MILLION)
  • 14.80 TABLE 80 CANADA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR SUPPLEMENTS, BY TYPE, 2022–2029 (USD MILLION)
  • 14.81 TABLE 81 CANADA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY DISEASE TYPE, 2022–2029 (USD MILLION)
  • 14.82 TABLE 82 CANADA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY ANIMAL TYPE, 2022–2029 (USD MILLION)
  • 14.83 TABLE 83 CANADA: CATTLE REPRODUCTIVE DISEASES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • 14.84 TABLE 84 CANADA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • 14.85 TABLE 85 EUROPE: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • 14.86 TABLE 86 EUROPE: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • 14.87 TABLE 87 EUROPE: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR DIAGNOSTICS, BY TYPE, 2022–2029 (USD MILLION)
  • 14.88 TABLE 88 EUROPE: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR PHARMACEUTICALS, BY TYPE, 2022–2029 (USD MILLION)
  • 14.89 TABLE 89 EUROPE: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR SUPPLEMENTS, BY TYPE, 2022–2029 (USD MILLION)
  • 14.90 TABLE 90 EUROPE: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY DISEASE TYPE, 2022–2029 (USD MILLION)
  • 14.91 TABLE 91 EUROPE: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY ANIMAL TYPE, 2022–2029 (USD MILLION)
  • 14.92 TABLE 92 EUROPE: CATTLE REPRODUCTIVE DISEASES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • 14.93 TABLE 93 EUROPE: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • 14.94 TABLE 94 GERMANY: KEY MACROINDICATORS
  • 14.95 TABLE 95 GERMANY: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • 14.96 TABLE 96 GERMANY: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR DIAGNOSTICS, BY TYPE, 2022–2029 (USD MILLION)
  • 14.97 TABLE 97 GERMANY: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR PHARMACEUTICALS, BY TYPE, 2022–2029 (USD MILLION)
  • 14.98 TABLE 98 GERMANY: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR SUPPLEMENTS, BY TYPE, 2022–2029 (USD MILLION)
  • 14.99 TABLE 99 GERMANY: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY DISEASE TYPE, 2022–2029 (USD MILLION)
  • 14.100 TABLE 100 GERMANY: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY ANIMAL TYPE, 2022–2029 (USD MILLION)
  • 14.101 TABLE 101 GERMANY: CATTLE REPRODUCTIVE DISEASES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • 14.102 TABLE 102 GERMANY: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • 14.103 TABLE 103 UK: KEY MACROINDICATORS
  • 14.104 TABLE 104 UK: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • 14.105 TABLE 105 UK: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR DIAGNOSTICS, BY TYPE, 2022–2029 (USD MILLION)
  • 14.106 TABLE 106 UK: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR PHARMACEUTICALS, BY TYPE, 2022–2029 (USD MILLION)
  • 14.107 TABLE 107 UK: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR SUPPLEMENTS, BY TYPE, 2022–2029 (USD MILLION)
  • 14.108 TABLE 108 UK: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY DISEASE TYPE, 2022–2029 (USD MILLION)
  • 14.109 TABLE 109 UK: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY ANIMAL TYPE, 2022–2029 (USD MILLION)
  • 14.110 TABLE 110 UK: CATTLE REPRODUCTIVE DISEASES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • 14.111 TABLE 111 UK: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • 14.112 TABLE 112 FRANCE: KEY MACROINDICATORS
  • 14.113 TABLE 113 FRANCE: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • 14.114 TABLE 114 FRANCE: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR DIAGNOSTICS, BY TYPE, 2022–2029 (USD MILLION)
  • 14.115 TABLE 115 FRANCE: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR PHARMACEUTICALS, BY TYPE, 2022–2029 (USD MILLION)
  • 14.116 TABLE 116 FRANCE: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR SUPPLEMENTS, BY TYPE, 2022–2029 (USD MILLION)
  • 14.117 TABLE 117 FRANCE: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY DISEASE TYPE, 2022–2029 (USD MILLION)
  • 14.118 TABLE 118 FRANCE: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY ANIMAL TYPE, 2022–2029 (USD MILLION)
  • 14.119 TABLE 119 FRANCE: CATTLE REPRODUCTIVE DISEASES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • 14.120 TABLE 120 FRANCE: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • 14.121 TABLE 121 ITALY: KEY MACROINDICATORS
  • 14.122 TABLE 122 ITALY: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • 14.123 TABLE 123 ITALY: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR DIAGNOSTICS, BY TYPE, 2022–2029 (USD MILLION)
  • 14.124 TABLE 124 ITALY: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR PHARMACEUTICALS, BY TYPE, 2022–2029 (USD MILLION)
  • 14.125 TABLE 125 ITALY: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR SUPPLEMENTS, BY TYPE, 2022–2029 (USD MILLION)
  • 14.126 TABLE 126 ITALY: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, DISEASE TYPE, 2022–2029 (USD MILLION)
  • 14.127 TABLE 127 ITALY: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY ANIMAL TYPE, 2022–2029 (USD MILLION)
  • 14.128 TABLE 128 ITALY: CATTLE REPRODUCTIVE DISEASES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • 14.129 TABLE 129 ITALY: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • 14.130 TABLE 130 SWITZERLAND: KEY MACROINDICATORS
  • 14.131 TABLE 131 SWITZERLAND: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • 14.132 TABLE 132 SWITZERLAND: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR DIAGNOSTICS, BY TYPE, 2022–2029 (USD MILLION)
  • 14.133 TABLE 133 SWITZERLAND: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR PHARMACEUTICALS, BY TYPE, 2022–2029 (USD MILLION)
  • 14.134 TABLE 134 SWITZERLAND: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR SUPPLEMENTS, BY TYPE, 2022–2029 (USD MILLION)
  • 14.135 TABLE 135 SWITZERLAND: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY DISEASE TYPE, 2022–2029 (USD MILLION)
  • 14.136 TABLE 136 SWITZERLAND: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY ANIMAL TYPE, 2022–2029 (USD MILLION)
  • 14.137 TABLE 137 SWITZERLAND: CATTLE REPRODUCTIVE DISEASES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • 14.138 TABLE 138 SWITZERLAND: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • 14.139 TABLE 139 SPAIN: KEY MACROINDICATORS
  • 14.140 TABLE 140 SPAIN: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • 14.141 TABLE 141 SPAIN: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR DIAGNOSTICS, BY TYPE, 2022–2029 (USD MILLION)
  • 14.142 TABLE 142 SPAIN: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR PHARMACEUTICALS, BY TYPE, 2022–2029 (USD MILLION)
  • 14.143 TABLE 143 SPAIN: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR SUPPLEMENTS, BY TYPE, 2022–2029 (USD MILLION)
  • 14.144 TABLE 144 SPAIN: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY DISEASE TYPE, 2022–2029 (USD MILLION)
  • 14.145 TABLE 145 SPAIN: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY ANIMAL TYPE, 2022–2029 (USD MILLION)
  • 14.146 TABLE 146 SPAIN: CATTLE REPRODUCTIVE DISEASES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • 14.147 TABLE 147 SPAIN: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • 14.148 TABLE 148 REST OF EUROPE: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • 14.149 TABLE 149 REST OF EUROPE: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR DIAGNOSTICS, BY TYPE, 2022–2029 (USD MILLION)
  • 14.150 TABLE 150 REST OF EUROPE: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR PHARMACEUTICALS, BY TYPE, 2022–2029 (USD MILLION)
  • 14.151 TABLE 151 REST OF EUROPE: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR SUPPLEMENTS, BY TYPE, 2022–2029 (USD MILLION)
  • 14.152 TABLE 152 REST OF EUROPE: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY DISEASE TYPE, 2022–2029 (USD MILLION)
  • 14.153 TABLE 153 REST OF EUROPE: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY ANIMAL TYPE, 2022–2029 (USD MILLION)
  • 14.154 TABLE 154 REST OF EUROPE: CATTLE REPRODUCTIVE DISEASES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • 14.155 TABLE 155 REST OF EUROPE: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • 14.156 TABLE 156 ASIA PACIFIC: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • 14.157 TABLE 157 ASIA PACIFIC: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • 14.158 TABLE 158 ASIA PACIFIC: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR DIAGNOSTICS, BY TYPE, 2022–2029 (USD MILLION)
  • 14.159 TABLE 159 ASIA PACIFIC: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR PHARMACEUTICALS, BY TYPE, 2022–2029 (USD MILLION)
  • 14.160 TABLE 160 ASIA PACIFIC: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR SUPPLEMENTS, BY TYPE, 2022–2029 (USD MILLION)
  • 14.161 TABLE 161 ASIA PACIFIC: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY DISEASE TYPE, 2022–2029 (USD MILLION)
  • 14.162 TABLE 162 ASIA PACIFIC: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY ANIMAL TYPE, 2022–2029 (USD MILLION)
  • 14.163 TABLE 163 ASIA PACIFIC: CATTLE REPRODUCTIVE DISEASES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • 14.164 TABLE 164 ASIA PACIFIC: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • 14.165 TABLE 165 JAPAN: KEY MACROINDICATORS
  • 14.166 TABLE 166 JAPAN: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • 14.167 TABLE 167 JAPAN: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR DIAGNOSTICS, BY TYPE, 2022–2029 (USD MILLION)
  • 14.168 TABLE 168 JAPAN: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR PHARMACEUTICALS, BY TYPE, 2022–2029 (USD MILLION)
  • 14.169 TABLE 169 JAPAN: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR SUPPLEMENTS, BY TYPE, 2022–2029 (USD MILLION)
  • 14.170 TABLE 170 JAPAN: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY DISEASE TYPE, 2022–2029 (USD MILLION)
  • 14.171 TABLE 171 JAPAN: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY ANIMAL TYPE, 2022–2029 (USD MILLION)
  • 14.172 TABLE 172 JAPAN: CATTLE REPRODUCTIVE DISEASES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • 14.173 TABLE 173 JAPAN: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • 14.174 TABLE 174 CHINA: KEY MACROINDICATORS
  • 14.175 TABLE 175 CHINA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • 14.176 TABLE 176 CHINA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR DIAGNOSTICS, BY TYPE, 2022–2029 (USD MILLION)
  • 14.177 TABLE 177 CHINA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR PHARMACEUTICALS, BY TYPE, 2022–2029 (USD MILLION)
  • 14.178 TABLE 178 CHINA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR SUPPLEMENTS, BY TYPE, 2022–2029 (USD MILLION)
  • 14.179 TABLE 179 CHINA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY DISEASE TYPE, 2022–2029 (USD MILLION)
  • 14.180 TABLE 180 CHINA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY ANIMAL TYPE, 2022–2029 (USD MILLION)
  • 14.181 TABLE 181 CHINA: CATTLE REPRODUCTIVE DISEASES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • 14.182 TABLE 182 CHINA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • 14.183 TABLE 183 INDIA: KEY MACROINDICATORS
  • 14.184 TABLE 184 INDIA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • 14.185 TABLE 185 INDIA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR DIAGNOSTICS, BY TYPE, 2022–2029 (USD MILLION)
  • 14.186 TABLE 186 INDIA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR PHARMACEUTICALS, BY TYPE, 2022–2029 (USD MILLION)
  • 14.187 TABLE 187 INDIA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR SUPPLEMENTS, BY TYPE, 2022–2029 (USD MILLION)
  • 14.188 TABLE 188 INDIA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY DISEASE TYPE, 2022–2029 (USD MILLION)
  • 14.189 TABLE 189 INDIA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY ANIMAL TYPE, 2022–2029 (USD MILLION)
  • 14.190 TABLE 190 INDIA: CATTLE REPRODUCTIVE DISEASES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • 14.191 TABLE 191 INDIA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • 14.192 TABLE 192 AUSTRALIA: KEY MACROINDICATORS
  • 14.193 TABLE 193 AUSTRALIA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • 14.194 TABLE 194 AUSTRALIA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR DIAGNOSTICS, BY TYPE, 2022–2029 (USD MILLION)
  • 14.195 TABLE 195 AUSTRALIA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR PHARMACEUTICALS, BY TYPE, 2022–2029 (USD MILLION)
  • 14.196 TABLE 196 AUSTRALIA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR SUPPLEMENTS, BY TYPE, 2022–2029 (USD MILLION)
  • 14.197 TABLE 197 AUSTRALIA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY DISEASE TYPE, 2022–2029 (USD MILLION)
  • 14.198 TABLE 198 AUSTRALIA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY ANIMAL TYPE, 2022–2029 (USD MILLION)
  • 14.199 TABLE 199 AUSTRALIA: CATTLE REPRODUCTIVE DISEASES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • 14.200 TABLE 200 AUSTRALIA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • 14.201 TABLE 201 SOUTH KOREA: KEY MACROINDICATORS
  • 14.202 TABLE 202 SOUTH KOREA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • 14.203 TABLE 203 SOUTH KOREA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR DIAGNOSTICS, BY TYPE, 2022–2029 (USD MILLION)
  • 14.204 TABLE 204 SOUTH KOREA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR PHARMACEUTICALS, BY TYPE, 2022–2029 (USD MILLION)
  • 14.205 TABLE 205 SOUTH KOREA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR SUPPLEMENTS, BY TYPE, 2022–2029 (USD MILLION)
  • 14.206 TABLE 206 SOUTH KOREA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY DISEASE TYPE, 2022–2029 (USD MILLION)
  • 14.207 TABLE 207 SOUTH KOREA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY ANIMAL TYPE, 2022–2029 (USD MILLION)
  • 14.208 TABLE 208 SOUTH KOREA: CATTLE REPRODUCTIVE DISEASES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • 14.209 TABLE 209 SOUTH KOREA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • 14.210 TABLE 210 REST OF ASIA PACIFIC: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • 14.211 TABLE 211 REST OF ASIA PACIFIC: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR DIAGNOSTICS, BY TYPE, 2022–2029 (USD MILLION)
  • 14.212 TABLE 212 REST OF ASIA PACIFIC: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR PHARMACEUTICALS, BY TYPE, 2022–2029 (USD MILLION)
  • 14.213 TABLE 213 REST OF ASIA PACIFIC: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR SUPPLEMENTS, BY TYPE, 2022–2029 (USD MILLION)
  • 14.214 TABLE 214 REST OF ASIA PACIFIC: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY DISEASE TYPE, 2022–2029 (USD MILLION)
  • 14.215 TABLE 215 REST OF ASIA PACIFIC: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY ANIMAL TYPE, 2022–2029 (USD MILLION)
  • 14.216 TABLE 216 REST OF ASIA PACIFIC: CATTLE REPRODUCTIVE DISEASES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • 14.217 TABLE 217 REST OF ASIA PACIFIC: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • 14.218 TABLE 218 LATIN AMERICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • 14.219 TABLE 219 LATIN AMERICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • 14.220 TABLE 220 LATIN AMERICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR DIAGNOSTICS, BY TYPE, 2022–2029 (USD MILLION)
  • 14.221 TABLE 221 LATIN AMERICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR PHARMACEUTICALS, BY TYPE, 2022–2029 (USD MILLION)
  • 14.222 TABLE 222 LATIN AMERICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR SUPPLEMENTS, BY TYPE, 2022–2029 (USD MILLION)
  • 14.223 TABLE 223 LATIN AMERICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY DISEASE TYPE, 2022–2029 (USD MILLION)
  • 14.224 TABLE 224 LATIN AMERICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY ANIMAL TYPE, 2022–2029 (USD MILLION)
  • 14.225 TABLE 225 LATIN AMERICA: CATTLE REPRODUCTIVE DISEASES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • 14.226 TABLE 226 LATIN AMERICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • 14.227 TABLE 227 BRAZIL: KEY MACROINDICATORS
  • 14.228 TABLE 228 BRAZIL: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • 14.229 TABLE 229 BRAZIL: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR DIAGNOSTICS, BY TYPE, 2022–2029 (USD MILLION)
  • 14.230 TABLE 230 BRAZIL: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR PHARMACEUTICALS, BY TYPE, 2022–2029 (USD MILLION)
  • 14.231 TABLE 231 BRAZIL: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR SUPPLEMENTS, BY TYPE, 2022–2029 (USD MILLION)
  • 14.232 TABLE 232 BRAZIL: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY DISEASE TYPE, 2022–2029 (USD MILLION)
  • 14.233 TABLE 233 BRAZIL: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY ANIMAL TYPE, 2022–2029 (USD MILLION)
  • 14.234 TABLE 234 BRAZIL: CATTLE REPRODUCTIVE DISEASES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • 14.235 TABLE 235 BRAZIL: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • 14.236 TABLE 236 MEXICO: KEY MACROINDICATORS
  • 14.237 TABLE 237 MEXICO: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • 14.238 TABLE 238 MEXICO: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR DIAGNOSTICS, BY TYPE, 2022–2029 (USD MILLION)
  • 14.239 TABLE 239 MEXICO: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR PHARMACEUTICALS, BY TYPE, 2022–2029 (USD MILLION)
  • 14.240 TABLE 240 MEXICO: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR SUPPLEMENTS, BY TYPE, 2022–2029 (USD MILLION)
  • 14.241 TABLE 241 MEXICO: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY DISEASE TYPE, 2022–2029 (USD MILLION)
  • 14.242 TABLE 242 MEXICO: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY ANIMAL TYPE, 2022–2029 (USD MILLION)
  • 14.243 TABLE 243 MEXICO: CATTLE REPRODUCTIVE DISEASES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • 14.244 TABLE 244 MEXICO: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • 14.245 TABLE 245 REST OF LATIN AMERICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • 14.246 TABLE 246 REST OF LATIN AMERICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR DIAGNOSTICS, BY TYPE, 2022–2029 (USD MILLION)
  • 14.247 TABLE 247 REST OF LATIN AMERICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR PHARMACEUTICALS, BY TYPE, 2022–2029 (USD MILLION)
  • 14.248 TABLE 248 REST OF LATIN AMERICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR SUPPLEMENTS, BY TYPE, 2022–2029 (USD MILLION)
  • 14.249 TABLE 249 REST OF LATIN AMERICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY DISEASE TYPE, 2022–2029 (USD MILLION)
  • 14.250 TABLE 250 REST OF LATIN AMERICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY ANIMAL TYPE, 2022–2029 (USD MILLION)
  • 14.251 TABLE 251 REST OF LATIN AMERICA: CATTLE REPRODUCTIVE DISEASES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • 14.252 TABLE 252 REST OF LATIN AMERICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • 14.253 TABLE 253 MIDDLE EAST & AFRICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • 14.254 TABLE 254 MIDDLE EAST & AFRICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • 14.255 TABLE 255 MIDDLE EAST & AFRICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR DIAGNOSTICS, BY TYPE, 2022–2029 (USD MILLION)
  • 14.256 TABLE 256 MIDDLE EAST & AFRICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR PHARMACEUTICALS, BY TYPE, 2022–2029 (USD MILLION)
  • 14.257 TABLE 257 MIDDLE EAST & AFRICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR SUPPLEMENTS, BY TYPE, 2022–2029 (USD MILLION)
  • 14.258 TABLE 258 MIDDLE EAST & AFRICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY DISEASE TYPE, 2022–2029 (USD MILLION)
  • 14.259 TABLE 259 MIDDLE EAST & AFRICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY ANIMAL TYPE, 2022–2029 (USD MILLION)
  • 14.260 TABLE 260 MIDDLE EAST & AFRICA: CATTLE REPRODUCTIVE DISEASES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • 14.261 TABLE 261 MIDDLE EAST & AFRICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • 14.262 TABLE 262 GCC COUNTRIES: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • 14.263 TABLE 263 GCC COUNTRIES: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR DIAGNOSTICS, BY TYPE, 2022–2029 (USD MILLION)
  • 14.264 TABLE 264 GCC COUNTRIES: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR PHARMACEUTICALS, BY TYPE, 2022–2029 (USD MILLION)
  • 14.265 TABLE 265 GCC COUNTRIES: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR SUPPLEMENTS, BY TYPE, 2022–2029 (USD MILLION)
  • 14.266 TABLE 266 GCC COUNTRIES: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY DISEASE TYPE, 2022–2029 (USD MILLION)
  • 14.267 TABLE 267 GCC COUNTRIES: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY ANIMAL TYPE, 2022–2029 (USD MILLION)
  • 14.268 TABLE 268 GCC COUNTRIES: CATTLE REPRODUCTIVE DISEASES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • 14.269 TABLE 269 GCC COUNTRIES: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • 14.270 TABLE 270 REST OF MIDDLE EAST & AFRICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • 14.271 TABLE 271 REST OF MIDDLE EAST & AFRICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR DIAGNOSTICS, BY TYPE, 2022–2029 (USD MILLION)
  • 14.272 TABLE 272 REST OF MIDDLE EAST & AFRICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR PHARMACEUTICALS, BY TYPE, 2022–2029 (USD MILLION)
  • 14.273 TABLE 273 REST OF MIDDLE EAST & AFRICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR SUPPLEMENTS, BY TYPE, 2022–2029 (USD MILLION)
  • 14.274 TABLE 274 REST OF MIDDLE EAST & AFRICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY DISEASE TYPE, 2022–2029 (USD MILLION)
  • 14.275 TABLE 275 REST OF MIDDLE EAST & AFRICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY ANIMAL TYPE, 2022–2029 (USD MILLION)
  • 14.276 TABLE 276 REST OF MIDDLE EAST & AFRICA: CATTLE REPRODUCTIVE DISEASES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • 14.277 TABLE 277 REST OF MIDDLE EAST & AFRICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • 14.278 TABLE 278 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET
  • 14.279 TABLE 279 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET: DEGREE OF COMPETITION
  • 14.280 TABLE 280 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET: PRODUCT FOOTPRINT
  • 14.281 TABLE 281 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET: DISEASE TYPE FOOTPRINT
  • 14.282 TABLE 282 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET: ANIMAL TYPE FOOTPRINT
  • 14.283 TABLE 283 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET: END-USER FOOTPRINT
  • 14.284 TABLE 284 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET: REGION FOOTPRINT
  • 14.285 TABLE 285 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
  • 14.286 TABLE 286 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS
  • 14.287 TABLE 287 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET: PRODUCT LAUNCHES, JANUARY 2021−AUGUST 2024
  • 14.288 TABLE 288 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET: DEALS, JANUARY 2021−AUGUST 2024
  • 14.289 TABLE 289 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET: EXPANSIONS, JANUARY 2021−AUGUST 2024
  • 14.290 TABLE 290 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET: OTHER DEVELOPMENTS, JANUARY 2021−AUGUST 2024
  • 14.291 TABLE 291 ZOETIS INC.: COMPANY OVERVIEW
  • 14.292 TABLE 292 ZOETIS INC: PRODUCTS OFFERED
  • 14.293 TABLE 293 ZOETIS INC.: DEALS, JANUARY 2021–AUGUST 2024
  • 14.294 TABLE 294 ZOETIS INC.: EXPANSIONS, JANUARY 2021–AUGUST 2024
  • 14.295 TABLE 295 ZOETIS INC.: OTHER DEVELOPMENTS, JANUARY 2021–AUGUST 2024
  • 14.296 TABLE 296 MERCK & CO., INC.: COMPANY OVERVIEW
  • 14.297 TABLE 297 MERCK & CO., INC.: PRODUCTS OFFERED
  • 14.298 TABLE 298 MERCK & CO., INC.: DEALS, JANUARY 2021–AUGUST 2024
  • 14.299 TABLE 299 MERCK & CO., INC.: OTHER DEVELOPMENTS, JANUARY 2021–AUGUST 2024
  • 14.300 TABLE 300 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: COMPANY OVERVIEW
  • 14.301 TABLE 301 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: PRODUCTS OFFERED
  • 14.302 TABLE 302 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–AUGUST 2024
  • 14.303 TABLE 303 VIRBAC: COMPANY OVERVIEW
  • 14.304 TABLE 304 VIRBAC: PRODUCTS OFFERED
  • 14.305 TABLE 305 VIRBAC: DEALS, JANUARY 2021–AUGUST 2024
  • 14.306 TABLE 306 VIRBAC: EXPANSIONS, JANUARY 2021–AUGUST 2024
  • 14.307 TABLE 307 ELANCO ANIMAL HEALTH INCORPORATED: COMPANY OVERVIEW
  • 14.308 TABLE 308 ELANCO ANIMAL HEALTH INCORPORATED: PRODUCTS OFFERED
  • 14.309 TABLE 309 ELANCO ANIMAL HEALTH INCORPORATED: DEALS, JANUARY 2021–AUGUST 2024
  • 14.310 TABLE 310 ELANCO ANIMAL HEALTH INCORPORATED: EXPANSIONS, JANUARY 2021–AUGUST 2024
  • 14.311 TABLE 311 VETOQUINOL S.A.: COMPANY OVERVIEW
  • 14.312 TABLE 312 VETOQUINOL S.A.: PRODUCTS OFFERED
  • 14.313 TABLE 313 CEVA SANTÉ ANIMALE: COMPANY OVERVIEW
  • 14.314 TABLE 314 CEVA SANTÉ ANIMALE: PRODUCTS OFFERED
  • 14.315 TABLE 315 CEVA SANTÉ ANIMALE: DEALS, JANUARY 2021–AUGUST 2024
  • 14.316 TABLE 316 IDEXX LABORATORIES, INC.: COMPANY OVERVIEW
  • 14.317 TABLE 317 IDEXX LABORATORIES, INC.: PRODUCTS OFFERED
  • 14.318 TABLE 318 IDEXX LABORATORIES, INC.: OTHER DEVELOPMENTS, JANUARY 2021–AUGUST 2024
  • 14.319 TABLE 319 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
  • 14.320 TABLE 320 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED
  • 14.321 TABLE 321 BIOCHEK SMART VETERINARY DIAGNOSTICS: COMPANY OVERVIEW
  • 14.322 TABLE 322 BIOCHEK SMART VETERINARY DIAGNOSTICS: PRODUCTS OFFERED
  • 14.323 TABLE 323 BIOCHEK SMART VETERINARY DIAGNOSTICS: EXPANSIONS, JANUARY 2021–AUGUST 2024
  • 14.324 TABLE 324 RING BIOTECHNOLOGY CO LTD.: COMPANY OVERVIEW
  • 14.325 TABLE 325 RING BIOTECHNOLOGY CO LTD.: PRODUCTS OFFERED
  • 14.326 TABLE 326 RING BIOTECHNOLOGY CO LTD.: PRODUCT LAUNCHES, JANUARY 2021–AUGUST 2024
  • 14.327 TABLE 327 SEQUENT SCIENTIFIC LIMITED: COMPANY OVERVIEW
  • 14.328 TABLE 328 SEQUENT SCIENTIFIC LIMITED: PRODUCTS OFFERED
  • 14.329 TABLE 329 HIPRA: COMPANY OVERVIEW
  • 14.330 TABLE 330 HIPRA: PRODUCTS OFFERED
  • 14.331 TABLE 331 QIAGEN N.V.: COMPANY OVERVIEW
  • 14.332 TABLE 332 QIAGEN N.V.: PRODUCTS OFFERED
  • 14.333 TABLE 333 INNOVATIVE DIAGNOSTICS: COMPANY OVERVIEW
  • 14.334 TABLE 334 INNOVATIVE DIAGNOSTICS: PRODUCTS OFFERED
  • 14.335 TABLE 335 INNOVATIVE DIAGNOSTICS: OTHER DEVELOPMENTS, JANUARY 2021–AUGUST 2024
List of Figures
325
  • 15.1 FIGURE 1 MARKET SEGMENTATION
  • 15.2 FIGURE 2 RESEARCH DESIGN
  • 15.3 FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY SIDE AND DEMAND SIDE PARTICIPANTS
  • 15.4 FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
  • 15.5 FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION
  • 15.6 FIGURE 6 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
  • 15.7 FIGURE 7 REVENUE SHARE ANALYSIS ILLUSTRATION: ZOETIS INC.
  • 15.8 FIGURE 8 SUPPLY SIDE ANALYSIS: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET (2023)
  • 15.9 FIGURE 9 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2022–2029)
  • 15.10 FIGURE 10 CAGR PROJECTIONS: SUPPLY SIDE ANALYSIS
  • 15.11 FIGURE 11 TOP-DOWN APPROACH
  • 15.12 FIGURE 12 DATA TRIANGULATION METHODOLOGY
  • 15.13 FIGURE 13 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION)
  • 15.14 FIGURE 14 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR DIAGNOSTICS, BY TYPE, 2024 VS. 2029 (USD MILLION)
  • 15.15 FIGURE 15 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR PHARMACEUTICAL PRODUCTS, BY TYPE, 2024 VS. 2029 (USD MILLION)
  • 15.16 FIGURE 16 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR SUPPLEMENTS, BY TYPE, 2024 VS. 2029 (USD MILLION)
  • 15.17 FIGURE 17 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY DISEASE TYPE, 2024 VS. 2029 (USD MILLION)
  • 15.18 FIGURE 18 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY ANIMAL TYPE, 2024 VS. 2029 (USD MILLION)
  • 15.19 FIGURE 19 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
  • 15.20 FIGURE 20 GEOGRAPHIC SNAPSHOT OF CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET
  • 15.21 FIGURE 21 RISING DEMAND FOR ANIMAL-DERIVED FOOD PRODUCTS TO DRIVE MARKET
  • 15.22 FIGURE 22 PHARMACEUTICALS SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN GERMANY IN 2023
  • 15.23 FIGURE 23 ASIA PACIFIC REGION TO DOMINATE MARKET DURING FORECAST PERIOD
  • 15.24 FIGURE 24 CHINA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
  • 15.25 FIGURE 25 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • 15.26 FIGURE 26 PRODUCTION OF MILK, BY REGION (MILLION METRIC TONS)
  • 15.27 FIGURE 27 PRODUCTION OF MEAT, BY REGION (MILLION METRIC TONS)
  • 15.28 FIGURE 28 PRODUCTION OF MEAT, BY ANIMAL TYPE (MILLION METRIC TONS)
  • 15.29 FIGURE 29 TOTAL NUMBER OF VETERINARIANS IN US, BY GENDER (2019−2023)
  • 15.30 FIGURE 30 NUMBER OF VETERINARIANS IN TOP FIVE EUROPEAN COUNTRIES (2023)
  • 15.31 FIGURE 31 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET: PORTER’S FIVE FORCES ANALYSIS
  • 15.32 FIGURE 32 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END USER
  • 15.33 FIGURE 33 KEY BUYING CRITERIA FOR END USERS
  • 15.34 FIGURE 34 DEVELOPMENT & APPROVAL PROCESS FOR ANIMAL PHARMACEUTICAL PRODUCTS
  • 15.35 FIGURE 35 PATENT PUBLICATION TRENDS (JANUARY 2013–DECEMBER 2023)
  • 15.36 FIGURE 36 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTIONS) FOR CATTLE REPRODUCTIVE DISEASE TREATMENT PATENTS (JANUARY 2013–DECEMBER 2023)
  • 15.37 FIGURE 37 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTIONS) FOR PORCINE REPRODUCTIVE DISEASE TREATMENT PATENTS (JANUARY 2013–DECEMBER 2023)
  • 15.38 FIGURE 38 TOP APPLICANT COUNTRIES/REGIONS FOR CATTLE & PORCINE REPRODUCTIVE DISEASE TREATMENT PATENTS (JANUARY 2013–DECEMBER 2023)
  • 15.39 FIGURE 39 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET: ECOSYSTEM ANALYSIS
  • 15.40 FIGURE 40 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET: SUPPLY CHAIN ANALYSIS
  • 15.41 FIGURE 41 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET: VALUE CHAIN ANALYSIS
  • 15.42 FIGURE 42 ADJACENT MARKETS FOR CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET
  • 15.43 FIGURE 43 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
  • 15.44 FIGURE 44 INVESTMENT & FUNDING ACTIVITIES IN CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, 2019–2023
  • 15.45 FIGURE 45 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET: GEOGRAPHIC SNAPSHOT
  • 15.46 FIGURE 46 EUROPE: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET SNAPSHOT
  • 15.47 FIGURE 47 REVENUE ANALYSIS OF KEY PLAYERS IN CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET (2019−2023)
  • 15.48 FIGURE 48 MARKET SHARE ANALYSIS OF KEY PLAYERS IN CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET (2023)
  • 15.49 FIGURE 49 RANKING OF KEY PLAYERS IN CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, 2023
  • 15.50 FIGURE 50 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS0, 2023
  • 15.51 FIGURE 51 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET: COMPANY FOOTPRINT
  • 15.52 FIGURE 52 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
  • 15.53 FIGURE 53 YEAR-TO-YEAR (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • 15.54 FIGURE 54 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • 15.55 FIGURE 55 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
  • 15.56 FIGURE 56 R&D EXPENDITURE OF KEY PLAYERS IN CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, 2021−2023
  • 15.57 FIGURE 57 ZOETIS INC.: COMPANY SNAPSHOT (2023)
  • 15.58 FIGURE 58 MERCK & CO., INC.: COMPANY SNAPSHOT (2023)
  • 15.59 FIGURE 59 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: COMPANY SNAPSHOT (2023)
  • 15.60 FIGURE 60 VIRBAC: COMPANY SNAPSHOT (2023)
  • 15.61 FIGURE 61 ELANCO ANIMAL HEALTH INCORPORATED: COMPANY SNAPSHOT (2023)
  • 15.62 FIGURE 62 VETOQUINOL S.A.: COMPANY SNAPSHOT (2023)
  • 15.63 FIGURE 63 IDEXX LABORATORIES, INC.: COMPANY SNAPSHOT (2023)
  • 15.64 FIGURE 64 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2023)
  • 15.65 FIGURE 65 SEQUENT SCIENTIFIC LIMITED: COMPANY SNAPSHOT (2023)
  • 15.66 FIGURE 66 QIAGEN N.V.: COMPANY SNAPSHOT (2023)

This study involved four major activities in estimating the current Cattle & porcine/swine reproductive diseases market size. Extensive research was conducted to collect information on the market as well as its peer and parent markets. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the value market. After that, market breakdown and data triangulation procedures were used to estimate the market size of segments and subsegments.

Secondary Research

The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Business, Factiva, and D&B Hoovers), white papers, annual reports, companies house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Cattle & porcine/swine reproductive diseases market. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply side include CEOs, consultants, subject-matter experts, directors, general managers, developers, and other key opinion leaders of the various companies that offer Cattle and porcine reproductive diseases product and service. Primary sources from the demand side include industry experts such as doctors, hospital directors and managers, and other medical professionals.

Primary research was conducted to identify segmentation types; industry trends; technology trends; key players; and key market dynamics such as drivers, restraints, opportunities, challenges, and key player strategies.

Note 1: Others include sales, marketing, and product managers.

Note 2: Their total revenues define the tiers of companies as of 2023, tier 1 = >USD 500 million, tier 2 = USD 200 million to USD 500 million, and tier 3 = < USD 200 million.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The total size of the Cattle & porcine/swine reproductive diseases market was arrived at after data triangulation from four different approaches, as mentioned below.

Bottom-up Approach: Revenues of individual companies were gathered from public sources and databases. Shares of the medical device cleaning businesses of leading players were gathered from secondary sources to the extent available. In certain cases, the share of the business unit was ascertained after a detailed analysis of various parameters, including product portfolio, market positioning, selling price, and geographic reach and strength. Individual shares or revenue estimates were validated through expert interviews.

Country level Analysis: The size of the Cattle & porcine/swine reproductive diseases market was obtained from the annual presentations of leading players and secondary data available in the public domain. The share of Cattle and porcine reproductive diseases products in the overall Cattle & porcine/swine reproductive diseases market was obtained from secondary data and validated by primary participants to arrive at the total Cattle & porcine/swine reproductive diseases market. Primary participants further validated the numbers.

Primary Interviews: As a part of the primary research process, individual respondent insights on the market size and growth were taken during the interview (regional and global, as applicable). All the responses were collated, and a weighted average was taken to derive a probabilistic estimate of the market size and growth rate.

Geographic market assessment (by region & country): The geographic assessment was done using the following approaches:

Approach 1: Geographic revenue contributions/splits of leading players in the market (wherever available) and respective growth trends

Approach 2: Geographic adoption trends for individual product segments by end users and growth prospects for each of the segments (assumptions and indicative estimates validated from primary interviews)

At each point, the assumptions and approaches were validated through industry experts contacted during primary research. Considering the limitations of data available from secondary research, revenue estimates for individual companies (for the overall Cattle & porcine/swine reproductive diseases market and geographic market assessment) were ascertained based on a detailed analysis of their respective product offerings, geographic reach/strength (direct or through distributors or suppliers), and the shares of the leading players in a particular region or country.

After complete market engineering with calculations for market statistics, market size estimations, market forecasting, market breakdown, and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods to perform market estimation and market forecasting for the overall market segments and subsegments listed in this report. Extensive qualitative and further quantitative analysis was also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Data Triangulation

After arriving at the market size, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed wherever applicable.

Approach to derive the market size and estimate market growth The market rankings for leading players were ascertained after a detailed assessment of their revenues from the Cattle and porcine reproductive diseases business using secondary data available through paid and unpaid sources. Owing to data limitations, in certain cases, the revenue share was arrived at after a detailed assessment of the product portfolios of major companies and their respective sales performance. At each point, this data was validated through primary interviews with industry experts.

Market Definition

The Cattle & porcine/swine reproductive diseases market includes products and services aimed at diagnosing, preventing, and treating reproductive diseases in cattle and pigs. These diseases can impact fertility, pregnancy, and overall reproductive health, affecting the livestock productivity. The market includes diagnostic products, veterinary pharmaceuticals, and supplements that target conditions like Brucellosis, Leptospirosis, Porcine Reproductive and Respiratory Syndrome (PRRS), and Bovine Viral Diarrhea (BVD) etc. Preventing these diseases is essential to avoid economic losses and maintain livestock productivity.

Stakeholders

  • Manufacturing companies of cattle and porcine reproductive diseases products
  • Distributors of products associated with cattle and porcine reproductive diseases
  • Dairy Farms
  • Beef Producers
  • Porcine Farms
  • Veterinary hospitals and clinics
  • Veterinary practitioners
  • Medical research institutes
  • Market research and consulting firms
  • Venture capitalists and investors
  • Regulatory agencies and government bodies

Report Objectives

  • To define, describe, and forecast the Cattle & porcine/swine reproductive diseases market, by product, disease type, animal type, end used type, and region.
  • To provide detailed information about the key factors influencing the market growth, such as drivers, restraints, opportunities, challenges, and industry trends
  • To strategically analyze the regulatory scenario, pricing trends, value chain, supply chain, ecosystem analysis, key stakeholders and buying criteria, technology scenario, patent scenario, and key conferences and events in the market
  • To analyze the micro markets with respect to individual growth trends, prospects, and contributions to the overall Cattle & porcine/swine reproductive diseases market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players.
  • To strategically profile the key players in this market and comprehensively analyze their market shares and core competencies.
  • To strategically analyze the Cattle & porcine/swine reproductive diseases market in five regions, namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
  • To track and analyze competitive developments such as product launch and pproval, acquisitions, partnerships, collaborations, and expansions in the Cattle & porcine/swine reproductive diseases market.

Previous Versions of this Report

"Our USP is "providing game-changing business opportunities reports with free customization" - so please feel free to provide us with your specific areas of interest / business challenges in much greater detail !!"

We appreciate your interest in this report. Once you fill out the form, you'll be immediately directed to an exclusive solution tailored to your needs. This high-value offering can help boost your revenue by 30% - a must-see opportunity for anyone looking to maximize growth.


By clicking the "Submit" button, you are agreeing to the Terms of Use and Privacy Policy.

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Cattle & Porcine/Swine Reproductive Diseases Market

DMCA.com Protection Status